Kaya A A - OmicsDI

Show results for

Unknown (1248)
Genomics (25)
Transcriptomics (15)
Proteomics (11)
Metabolomics (3)

Organisms

Homo sapiens (22)
Mus musculus (5)
Campylobacter coli (1)
Populus nigra (1)
Caenorhabditis elegans (1)
Danio rerio (1)
Bacteria (1)
Bombyx mori (1)
Bos taurus (1)
Corynebacterium glutamicum ATCC 13032 (1)
Coxsackievirus (1)
Escherichia coli (1)
Heterorhabditis megidis (1)
Steinernema carpocapsae (1)

Organisms

Homo sapiens (8)
Mus musculus (3)
Saccharomyces cerevisiae (1)
Caenorhabditis elegans (1)

Repository

biostudies-arrayexpress (16)
ENA (16)
pride (11)
EGA (8)
MetaboLights (3)

Tissue

Cell culture (2)
Liver (2)
Brain (1)
Dendritic cell (1)
Lymph node (1)
Permanent cell line cell (1)
Skin (1)
Whole body (1)

Disease

Idiopathic dilated cardiomyopathy (1)
Brain cancer (1)
Wounds and Injuries (1)

Technology Type

Mass Spectrometry (11)
Shotgun proteomics (7)
Mass spectrometry (3)
Bottom-up proteomics (3)
Illumina, Illumina 300 Duo V2 - Bead Studio (1)
Illumina_Infinium_HumanMethylation450, Illumina_HumanHT-12v4 (1)
Affinity purification coupled with mass spectrometry proteomics (1)
Data-dependent acquisition (1)
Data-independent acquisition (1)
Gel-based experiment (1)
Mass spectrometry imaging (1)
SWATH MS (1)

Instrument Platform

NextSeq 2000 (2)
Illumina NovaSeq 6000 (1)
Illumina HiSeq 4000 (1)
Capillary electrophoresis MS - negative (1)
Capillary electrophoresis MS - positive (1)
Flow injection analysis MS - positive (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2026 (5)
2015 (5)
2014 (3)
2023 (3)
2022 (3)
2024 (2)
2016 (2)
2010 (2)
2021 (2)
2020 (1)
2019 (1)
2011 (1)

CHEBI ID

CHEBI:10049 (1)
CHEBI:10093 (1)
CHEBI:101085 (1)
CHEBI:109895 (1)
CHEBI:1109 (1)
CHEBI:12387 (1)
CHEBI:124991 (1)
CHEBI:125535 (1)
CHEBI:131887 (1)
CHEBI:131924 (1)
CHEBI:132448 (1)
CHEBI:132883 (1)
CHEBI:133026 (1)
CHEBI:133094 (1)
CHEBI:133657 (1)
CHEBI:133662 (1)
CHEBI:133756 (1)
CHEBI:133758 (1)
CHEBI:134092 (1)
CHEBI:134281 (1)
CHEBI:134418 (1)
CHEBI:134442 (1)
CHEBI:134454 (1)
CHEBI:134548 (1)
CHEBI:134583 (1)
CHEBI:135654 (1)
CHEBI:135736 (1)
CHEBI:135876 (1)
CHEBI:135893 (1)
CHEBI:135954 (1)

Metabolite Name

(1'S,2R,2'R,10'S,11'S,15'S)-17'-hydroxy-2',15'-dimethylspiro[oxolane-2,14'-tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane]-6',8'-diene-5,5'-dione (1)
(1-{1-[(4-hydroxy-3-methoxyphenyl)methyl]-7,8-dimethoxy-2,2-dimethyl-1,2,3,4-tetrahydro-2λ⁵-isoquinolin-2-yl}ethylidene)-λ⁴-oxidanyliumyl (1)
(10,14a-dihydroxy-2,2,4a,6a,6b,9,9,12a-octamethyl-docosahydropicen-13-yl)oxidanesulfonic acid (1)
(10S,14S)-10,14,20-trimethyl-16-methylidene-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁷,²²]tetracosan-5-ylium-7-olate (1)
(12aR)-4-(dimethylamino)-4a,5,10,12a-tetrahydroxy-6-methylidene-1,2,3,4,4a,5,5a,6,11,11a,12,12a-dodecahydrotetracene-1,3,11,12-tetrone (1)
(12aR)-7-chloro-4-(dimethylamino)-4,6,10,12a-tetrahydroxy-1,2,3,4,4a,5,5a,6,11,11a,12,12a-dodecahydrotetracene-1,3,11,12-tetrone (1)
(12aS)-4,7-bis(dimethylamino)-10,12,12a-trihydroxy-1,3,11-trioxo-9-(2-oxoacetamido)-1,2,3,4,4a,5,5a,6,11,11a,12,12a-dodecahydrotetracene-2-carboximidic acid (1)
(12aS)-9-{[2-(tert-butylamino)-1-hydroxyethylidene]amino}-4,7-bis(dimethylamino)-5,10,12,12a-tetrahydroxy-1,3,11-trioxo-1,2,3,4,4a,5,5a,6,11,12a-decahydrotetracene-2-carboximidic acid (1)
(13-{[5-(acetyloxy)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,6,6,11,15-pentamethyl-14-(6-methylhept-5-en-2-yl)-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-9-yl)oxidanesulfonic acid (1)
(13R)-5-(3,4-dihydroxyphenyl)-6,9,17,19,21-pentahydroxy-13-(4-hydroxyphenyl)-4,12,14-trioxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁵,²⁰]henicosa-2(11),3(8),5,9,15,17,19-heptaen-7-one (1)
(15Z)-Octadec-15-en-9,11,13-triynoic acid (1)
(1R)-1,4-bis({[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy})-3-hydroxy-5-(sulfooxy)cyclohexane-1-carboxylic acid (1)
(1R,16Z,24E,26E,28Z)-1,18,26,27-tetrahydroxy-19,30-dimethoxy-12-[1-(3-methoxy-4-oxocyclohexyl)propan-2-yl]-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0⁴,⁹]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone (1)
(1R,16Z,24E,26E,28Z)-1,18-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)propan-2-yl]-19,30-dimethoxy-15,17,21,23,29-pentamethyl-35-methylidene-11,36-dioxa-4-azatricyclo[30.3.1.0⁴,⁹]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone (1)
(1R,2R,3R,11S,12S,14R,26R)-5,6',7',12-tetrahydroxy-6-methoxy-7,21,30-trimethyl-27-oxo-3',4'-dihydro-2'H-17,19,28-trioxa-24-thia-13,30-diazaspiro[heptacyclo[12.9.6.1³,¹¹.0²,¹³.0⁴,⁹.0¹⁵,²³.0¹⁶,²⁰]triacontane-26,1'-isoquinoline]-4(9),5,7,15(23),16(20),21-hexaen-22-yl acetate (1)
(1R,2S,3R,4R,5S,6R,7S)-1,3,4,5,7,8,9,10,10-Nonachlorotricyclo[5.2.1.0²,⁶]dec-8-ene (1)
(1R,6S,12R,15S)-5,5-Dimethyl-11,13-dioxatetracyclo[7.5.1.0¹,⁶.0¹²,¹⁵]pentadec-8-ene (1)
(1R,9S,18Z,24R)-12-[1-(4-chloro-3-hydroxycyclohexyl)prop-1-en-2-yl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.0⁴,⁹]octacos-18-ene-2,3,10,16-tetrone (1)
(1R,9S,18Z,24R)-12-[1-(4-chloro-3-methoxycyclohexyl)prop-1-en-2-yl]-17-ethyl-1,14-dihydroxy-13-(hydroxymethyl)-23,25-dimethoxy-19,21,27-trimethyl-11,28-dioxa-4-azatricyclo[22.3.1.0⁴,⁹]octacos-18-ene-2,3,10,16-tetrone (1)
(1S)-1,3,4-trihydroxy-5-(sulfooxy)cyclohexane-1-carboxylic acid (1)
(1S,16Z,24E,26E,28Z)-1,18-dihydroxy-12-{1-[4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-15-(hydroxymethyl)-19,30-dimethoxy-17,21,23,29,35-pentamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0⁴,⁹]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone (1)
(1S,16Z,24E,26E,28Z)-1,18-dihydroxy-12-{1-[4-(2-hydroxyethoxy)-5-methoxy-2-oxocyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0⁴,⁹]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone (1)
(1S,2R,10S,11S,14R,15R)-2,15-Dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-ene (1)
(1S,2S,10S,11S,15R)-14-(5,6-dimethylheptan-2-yl)-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-5,17-diol (1)
(1S,2S,5R,7R,10S,11S,14R,15S,17S)-14-[(1R)-1,2-Dihydroxyethyl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-5,14,17-triol (1)
(1S,2S,5S,10R,11S,14R,15R)-14-[(2R,5R)-5-Ethyl-6-methylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-5-ol (1)
(1S,2S,7S,10R,15R)-2,15-dimethyl-14-(1,4,6-trihydroxy-6-methylheptan-2-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane-5,9,16-triol (1)
(1S,5R,13R,17S)-15-[(1S,3S,5R,13R)-10,14-Dimethoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10,14,16-pentaen-3-yl]-17-hydroxy-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10,15-tetraen-14-one (1)
(2-Aminoethoxy)[(2R)-2-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]-3-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyloxy]propoxy]phosphinic acid (1)
(2-Aminoethoxy)[(2R)-2-[(5Z,8Z,11Z)-icosa-5,8,11-trienoyloxy]-3-[(9Z)-octadeca-1,9-dien-1-yloxy]propoxy]phosphinic acid (1)

First Public Date

2021 (4)
2026 (3)
2022 (3)
2025 (2)
2024 (2)
2023 (1)
2019 (1)

Study type

Transcription profiling by array (6)
RNA-seq of coding RNA (5)
CUT&RUN (3)
Comparative genomic hybridization by array (1)
ChIP-seq (1)

Release Date

2025 (207)
2022 (136)
2024 (126)
2023 (108)
2021 (83)
2020 (68)
2018 (60)
2011 (51)
2010 (50)
2019 (48)
2014 (45)
2012 (43)
2009 (40)
2017 (35)
2013 (33)
2016 (31)
2008 (31)
2026 (30)
2015 (29)
2006 (3)
2005 (3)
2007 (2)
2004 (2)

Lab affiliation

Aix Marseille Univ, CNRS, INSERM, Institut Paoli Calmettes - Marseille Proteomics (1)
Biozentrum, University of Basel, Switzerland (1)
Center for Medical Biotechnology, VIB, 9000 Ghent, Belgium. Department for Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium. VIB Proteomics Core, VIB, 9000 Ghent, Belgium. (1)
IBG-1: Biotechnology Forschungszentrum Juelich (1)
IGBMC, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France, UMR7104, UMR-S 1258. (1)
IMB Mainz, Germany (1)
Max-Planck-Institute for Biology of Ageing Department of Mitochondrial Proteostasis Joseph-Stelzmann-Str. 9b 50931 Cologne (1)
Maynooth University, Ireland (1)
Sequence database group (1)
University of Health Sciences Turkey (1)
Yale University (Keck MS & Proteomics Resource) (1)

Previous page
1 / 131
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 131
Next page

Sort by:

Relevance

Page size

Early postnatal metabolic profile in neonates with different birth weight status: A pilot study

INTRODUCTION: Restricted or enhanced intrauterine growth is associated with elevated risks of early and late metabolic problems in humans. Metabolomics based on amino acid and carnitine/acylcarnitine profile may have a role in fetal and early postnatal energy metabolism. In this ...

2021-04-28 | MTBLS2376 | MetaboLights

Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival

The spread of cancer to bone is invariably fatal, with complex cross-talk between tumor cells and the bone microenvironment responsible for driving disease progression. By combining in silico analysis of patient datasets with metabolomic profiling of prostate cancer cells cultured with bone cells...

2024-08-19 | MTBLS3973 | MetaboLights

Genome-wide binding sites of Progesterone receptor (PGR) isoforms PGR-A and PGR-B during differentiation of human endometrial stromal cells

We report the genome-wide binding sites of PGR-A and PGR-B at 2h of in vitro differentiation of human endometrial stromal cells that express either PGR-A or PGR-B. Progesterone, acting through the progesterone receptors (PGRs), is one of the most critical regulators of endometrial differentiation, k...

ORGANISM(S): Homo sapiens

2015-04-27 | E-GEOD-62475 | biostudies-arrayexpress

Protocol for a quasi-experimental study to assess the feasibility, acceptability and costs of multiple first-lines artemisinin-based combination therapies for uncomplicated malaria in the Kaya health district, Burkina Faso.

Not available

S-EPMC7887347 | biostudies-literature

Attitudes, practices, and determinants of community care-seeking behaviours for fever/malaria episodes in the context of the implementation of multiple first-line therapies for uncomplicated malaria in the health district of Kaya, Burkina Faso.

Not available

S-EPMC9153091 | biostudies-literature

Scenario-based Kaya identity analysis for city-level carbon dioxide emissions.

Not available

S-EPMC12334010 | biostudies-literature

Introducing onsite antenatal syphilis screening in Burkina Faso: implementation and evaluation of a feasibility intervention tailored to a local context.

Not available

S-EPMC5450306 | biostudies-literature

Evaluation of the implementation fidelity of the seasonal malaria chemoprevention intervention in Kaya health district, Burkina Faso.

Not available

S-EPMC5706718 | biostudies-literature

"As it is about that, they do as they please": Women's experience of the accessibility and acceptability of postabortion care in Kaya, Burkina Faso.

Not available

S-EPMC12782387 | biostudies-literature

Expression data of PGR isoforms, PRA and PRB, regulated genes in differentiating human endometrial stromal cells

gene expression at 6h of differentiation of Human endometrial stromal cell expressing either or both of PRA and PRB Endogenous PGR expression is silenced with siRNA mediated knockdown. Then, cells are transduced with adenovirus exressing flag tagged PRA or flag tagged PRB. Human endometrial stromal ...

ORGANISM(S): Homo sapiens

2015-04-27 | E-GEOD-48853 | biostudies-arrayexpress

Previous page
1 / 131
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 131
Next page

Sort by:

Relevance

Page size

1302 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets